Retrospective analysis of risk factors for fatigue in clinical trial patients (pts) with metastatic renal cell carcinoma (mRCC).

被引：0

作者：

Gore, Martin Eric

Gruenwald, Viktor

Motzer, Robert John

Quinn, David I.

Rini, Brian I.

Lin, Xun

Perkins, Julia Jane

Simantov, Ronit

Choueiri, Toni K.

机构：

[1] Royal Marsden NHS Fdn Trust, London, England

[2] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany

[3] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[4] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA

[5] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA

[6] Pfizer Oncol, San Diego, CA USA

[7] Pfizer Oncol, New York, NY USA

[8] Dana Farber Canc Inst, Boston, MA 02115 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e15624

引用

页数：1